A licensee possessing a Type A specific license of broad scope for medical use, issued under Part 33 of this chapter, is exempt from—

(a) The provisions of §35.12(d) regarding the need to file an amendment to the license for medical use of byproduct material, as described in §35.1000;

(b) The provisions of §35.13(b);

(c) The provisions of §35.13(f) regarding additions to or changes in the areas of use at the addresses identified in the application or on the license;

(d) The provisions of §35.14(a);

(e) The provisions of §35.14(b)(1) for an authorized user, an authorized nuclear pharmacist, an authorized medical physicist, or an ophthalmic physicist;

(f) The provisions of §35.14(b)(5).

(g) The provisions of §35.49(a).

[67 FR 20370, Apr. 24, 2002, as amended at 72 FR 55931, Oct. 1, 2007; 83 FR 33103, July 16, 2018]